Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD.
Saved in:
| Title: | Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD. |
|---|---|
| Authors: | Mehta D; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Davis M; Medicus Economics LLC, Milton, MA, USA., Epstein AJ; Medicus Economics LLC, Milton, MA, USA., Wensel B; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Grinnell T; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Thach A; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Williams GR; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. |
| Source: | Journal of medical economics [J Med Econ] 2021 Jan-Dec; Vol. 24 (1), pp. 939-948. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2021.1960682 |
